abstract |
An agent for the prophylaxis or treatment of glaucoma comprising an angiotensin II antagonist of formula (I) wherein the R1 represents a group selected from (Ia) - (If), and at least one compound selected from adrenaline receptor blockers, prostaglandins and carbonic anhydrase inhibitors as active ingredients. |